Davila-Garcia DM, Falconer T, Pratt N, Natarajan K, et al. Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence. J Diabetes Complications 2025;39:109114.
PMID: 40582069